Nalini Singh, MD, MPH, is professor emeritus-in-residence of pediatrics at the Schools of Medicine and Health Care Sciences and Public Health at The George Washington University, Washington, DC. She has worked for over three decades in infectious diseases and infection prevention, including serving as chair of the Division of Pediatric Infectious Diseases at Children’s National for 12 years (2000-2012). She has worked in positions of high responsibility in the US as well as in other parts of the world and has collaborated with investigators in projects funded by the European Union. She is a member of WHO’s Guidelines committee and expert steering group supporting the Infection Prevention Control Unit. She was a consultant to the United Nations (WHO and PAHO) infection prevention programs, as well as to the CDC from 2016 to 2019, where she worked on the development of guidelines for the prevention of transmission of MRSA and central line-associated infections in neonatal intensive care units. In the era of the COVID-19 pandemic, she has been involved in infection prevention initiatives and the use of novel technologies, such as cold adaptive plasma for inactivating SARS-COV-2 virus. Dr Singh received her pediatric training at the University of Massachusetts Medical Center and her infectious diseases training at the National Institutes of Health in Bethesda, MD. She also holds a Master of Public Health and graduate certificate in health information technology from The George Washington University.